Comprehensive Digestive Stool Analysis (CDSA)™

Comprehensive Digestive Stool Analysis (CDSA)™

The Comprehensive Digestive Stool Analysis (CDSA)™ offers a comprehensive look at the overall health of the gastrointestinal (GI) tract. The (CDSA)™ is the original non-invasive evaluation of gastrointestinal function that includes analyses of digestion, absorption, bacterial balance, and yeast. This gastrointestinal test profile is recommended for patients with diffuse and non-specific GI-related symptoms such as IBS, indigestion, dysbiosis, constipation, and diarrhea.

Digestive Complaints are Among the Most Common Reasons that Individuals Seek Medical Care
Evidence suggests that both local and systemic health issues may begin as imbalances in GI function. This diagnostic gastrointestinal stool test provides immediate, actionable clinical information for the estimated 50% of all patients seen by primary care practitioners who have GI complaints including IBS.

Consequences of Imbalanced Gastrointestinal Health:

  • Irritable Bowel Syndrome (IBS) can be the result of maldigestion, malabsorption, dysbiosis, and/or inflammation
  • Maldigestion can result in GI symptoms such as gas, bloating, abdominal pain, constipation or diarrhea
  • Chronic maldigestion can lead to bacterial/fungal overgrowth and alterations in gut permeability. Toxins and large molecules that escape the intestinal barrier can enter the general circulation, inflame the liver, burden the body’s detoxification system, and increase the risk for food allergies, joint disease, and imbalances in overall health.
  • Malabsorption can lead to deficiencies of nutrients, proteins, carbohydrates, and fats. This can result in long term health complications such as anemia, malnutrition, impaired metabolism and other diseases, such as osteoporosis.
  • Chronic dysbiosis can lower the levels of beneficial short chain fatty acids and alter bacterial metabolic activity, thereby increasing the risk of carcinogenesis, hormonal imbalance, and GI inflammation
  • Altered GI immune function and exposure to bacterial pathogens can lead to diarrhea, mucosal inflammation, intestinal permeability, toxin production, and auto-immune disorders

Test Type: Stool Analysis

ANALYTE LIST: 

  • Acetate %
  • Bacteriology Culture, aerobic
  • Bacteriology Culture, aerobic x 3
  • Bacteriology Culture, anaerobic
  • Beneficial SCFAs
  • Beta-Glucuronidase
  • Cholesterol
  • Chymotrypsin
  • Color
  • Fecal Lactoferrin
  • Long Chain Fatty Acids
  • Meat Fibers and Vegetable Fibers
  • Mucus
  • Occult Blood
  • Phospholipids
  • Propionate %
  • Putrefactive SCFAs
  • Total Fecal Fat
  • Triglycerides
  • Yeast Culture
  • n-Butyrate %
  • pH

CPT CODES: 

  •  Bacteriology Culture, aerobic87045  
  •  Bacteriology Culture, aerobic x 387046  
  •  Bacteriology Culture, anaerobic87075  
  •  Beneficial SCFAs82492  
  •  Beta-Glucuronidase84311  
  •  Cholesterol82715  
  •  Chymotrypsin84311  
  •  Fecal Lactoferrin83630  
  •  Long Chain Fatty Acids82725  
  •  Meat Fibers and Vegetable Fibers89160  
  •  Occult Blood82274  
  •  Phospholipids82715  
  •  Triglycerides82715  
  •  Yeast Culture87102  
  •  pH83986  

Specimen Requirements:  5cc stool in each vial - Formalin, Cary Blair and 1 white-top cup

Turn Around Time: 

14 Days
Test Descriptions: 

Additional Information: 


© 1998 - 2014 Genova Diagnostics (GDX)
This website is intended for educational purposes only. It is not meant for use as diagnostic information and is part of Genova Diagnostics' communication with physicians and patients.